Eton, O., S. S. Legha, et al. (2002). "Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial." J Clin Oncol 20(8): 2045-52. 53. Flamand, V., T. Sornasse , et al. (1994). "Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resi stance in vivo." Eur J Immunol 24(3): 605- 10. 54. Fogel-Petrovic, M., J. A. Long, et al. (2007). "Physiological concentrations of transforming growth factor beta1 selectiv ely inhibit human dendritic cell function." Int Immunopharmacol 7(14): 1924-33. 55. Fontana, A., K. Frei, et al. (1989). "Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice." J Immunol 143 (10): 3230- 4. 56. Forni, G., M. Giovarelli, et al. (1985). "Lymphokine-activated tumor inhibition in vivo. I. The local administration of interl eukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth." J Immunol 134(2): 1305-11. 57.